168 related articles for article (PubMed ID: 3813276)
1. [Intravenous theophylline: adaptation of dosage to blood theophylline levels at admission and to clearance].
Laaban JP; Dupeyron JP; Guyon F; Drieu L; Rochemaure J; Fabiani P
Ann Med Interne (Paris); 1986; 137(5):415-9. PubMed ID: 3813276
[TBL] [Abstract][Full Text] [Related]
2. Reliability of theophylline clearance in determining chronic oral dosage regimens.
Slotfeldt ML; Johnson CE; Grambau G; Weg JG
Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
[TBL] [Abstract][Full Text] [Related]
3. [Theophylline overdoses on admission to a resuscitation unit].
Laaban JP; Dupeyron JP; Coignet MC; Bedos JP; Poirier T; Rochemaure J
Rev Mal Respir; 1987; 4(3):127-32. PubMed ID: 3616118
[TBL] [Abstract][Full Text] [Related]
4. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
[TBL] [Abstract][Full Text] [Related]
5. Early estimate of theophylline clearance during intravenous infusion.
Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
[TBL] [Abstract][Full Text] [Related]
6. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
[TBL] [Abstract][Full Text] [Related]
7. Prediction of intravenous theophylline dosage based on a single, nonsteady-state concentration: a clinical study of childhood status asthmaticus.
Kurland G; Anderson DA; Mitsuoka JC; Marquardt ED
Pediatrics; 1988 Dec; 82(6):880-3. PubMed ID: 3186378
[TBL] [Abstract][Full Text] [Related]
8. Serum theophylline profile with once-daily theophylline (Uniphyl) following conversion from intravenous theophylline in adult asthmatic patients.
Fradette M; Babich M; Friesen EG; Archibald JS; Babul N
Clin Ther; 1994; 16(2):160-8. PubMed ID: 8062311
[TBL] [Abstract][Full Text] [Related]
9. Theophylline: constant-rate infusion predictions.
Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Chiou method for determining theophylline dosages.
Johnson MH; Burkle WS
Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
[TBL] [Abstract][Full Text] [Related]
11. [Asthma patients requiring unusually high doses of theophylline].
Matsumura Y; Shiga M; Otsuka H; Tomoe Y; Sugiyama H; Nakamura T
Arerugi; 1989 Mar; 38(3):272-6. PubMed ID: 2751434
[TBL] [Abstract][Full Text] [Related]
12. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
[TBL] [Abstract][Full Text] [Related]
13. Prediction of theophylline clearance using condition correction factors.
Haumschild MJ; Murphy JE
Clin Pharm; 1985; 4(1):59-64. PubMed ID: 3971684
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of 11 methods for predicting theophylline dose.
Rodvold KA; Paloucek FP; Zell M
Clin Pharm; 1986 May; 5(5):403-8. PubMed ID: 3720210
[TBL] [Abstract][Full Text] [Related]
15. Macrolide antibiotics and serum theophylline levels in relation to the severity of respiratory impairment: a comparison between the effects of erythromycin and josamycin.
Bartolucci L; Gradoli C; Vincenzi V; Iapadre M; Valori C
Chemioterapia; 1984 Oct; 3(5):286-90. PubMed ID: 6532544
[TBL] [Abstract][Full Text] [Related]
16. [Importance of the laboratory in optimizing anti-asthma therapy with theophylline].
Snidero M
Quad Sclavo Diagn; 1987 Mar; 23(1):72-91. PubMed ID: 3327089
[TBL] [Abstract][Full Text] [Related]
17. System for clinical pharmacokinetic monitoring of theophylline therapy.
Koup JR; Schentag JJ; Vance JW; Kuritzky PM; Pyszczynski DR; Jusko WJ
Am J Hosp Pharm; 1976 Sep; 33(9):949-56. PubMed ID: 790952
[TBL] [Abstract][Full Text] [Related]
18. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
19. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
20. [Severe neurologic complications secondary to poisoning by slow-release theophylline].
Carpentier F; Pison C; Barnoud D; Guignier M; Paramelle B
Rev Pneumol Clin; 1987; 43(4):182-5. PubMed ID: 3671969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
